EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeit

Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-Analysis

Alvi H Islam, Claudia Alvizuri, Hailemichael Desalegn, Emily Stephenson, Francisco Idalsoaga, Luis Antonio Diaz, John K MacDonald, Gene Y Im, Ashwani K Singal, Vipul Jairath, Mohammad Qasim Khan, Juan Pablo Arab

Clinical Gastroenterology and Hepatology · 2026-03 · 24 (3) · 606-620

DOI: 10.1016/j.cgh.2025.05.016 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-03. Verfasst von Alvi H Islam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Western University, London Health Sciences Center, London, Ontario, Canada. Hauptthemen laut MEDLINE: Hepatitis, Alcoholic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Alcohol-associated hepatitis (AH) is a severe form of alcohol-associated liver disease, with a short-term mortality of up to 50% within 3 months. The aim of this systematic review was to determine the optimal pharmacological treatment for severe AH that results in better survival outcomes. METHODS: MEDLINE, EMBASE, and CENTRAL were searched through February 16, 2025, for randomized controlled trials (RCTs) of medical therapy for adults with severe AH. The primary outcome was mortality at 28 days. Secondary outcomes included mortality at 90 days, adverse events, the incidence of hepatorenal syndrome, acute kidney injury or infections, and liver transplantation rates. Pooled risk ratios (RRs) and 95% confidence intervals (CIs) were calculated for each outcome. GRADE was used to assess certainty of evidence. RESULTS: Fifty-two RCTs (5121 participants) were included in the review. A survival benefit at 28 days was observed for corticosteroids over placebo (RR, 0.62; 95% CI, 0.41‒0.95), for corticosteroids plus N-acetylcysteine over corticosteroids alone (RR, 0.35; 95% CI, 0.16‒0.78), for granulocyte colony-stimulating factor combined plus pentoxifylline over pentoxifylline alone (RR, 0.27; 95% CI, 0.13‒0.54), and metadoxine combined with corticosteroids over corticosteroids alone (RR, 0.47; 95% CI, 0.25‒0.90) or pentoxifylline (RR, 0.50; 95% CI, 0.26‒0.96). The certainty of evidence ranged from very low to moderate. CONCLUSIONS: Low certainty evidence supports the efficacy of corticosteroids as first line therapy for eligible patients with severe AH. The certainty of the evidence supporting other therapies ranges from low to moderate. Further studies are needed to confirm these benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis, AlcoholicHumansRandomized Controlled Trials as TopicAdrenal Cortex HormonesAcetylcysteinePentoxifyllineTreatment Outcome

Stichwörter der Autor:innen

AlcoholAlcoholic HepatitisManagement of AHMeta-analysisSystematic Review

Substanzen

Adrenal Cortex HormonesAcetylcysteinePentoxifylline

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Western University, London Health Sciences Center, London, Ontario, Canada.
  • Department of Gastroenterology, Cayetano Heredia National Hospital, Lima, Peru.
  • Alimentiv, London, Ontario, Canada; Toronto Centre for Liver Disease (TCLD), University of Toronto, Toronto, Ontario, Canada.
  • Division of Gastroenterology, Department of Medicine, Western University, London Health Sciences Center, London, Ontario, Canada; Department of Gastroenterology, Escuela de Medicina, Pontificia Universidad Católica de C…
  • Department of Gastroenterology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San…
  • Alimentiv, London, Ontario, Canada.

Zitieren

APA

Islam, A. H., Alvizuri, C., Desalegn, H., Stephenson, E., Idalsoaga, F., Diaz, L. A., MacDonald, J. K., Im, G. Y., Singal, A. K., Jairath, V., Khan, M. Q., & Arab, J. P. (2026). Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 24(3), 606-620. https://doi.org/10.1016/j.cgh.2025.05.016

Vancouver

Islam AH, Alvizuri C, Desalegn H, Stephenson E, Idalsoaga F, Diaz LA, et al. Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. 2026;24(3):606-620. doi:10.1016/j.cgh.2025.05.016

BibTeX
@article{Islam2026,
  author = {Islam, Alvi H and Alvizuri, Claudia and Desalegn, Hailemichael and Stephenson, Emily and Idalsoaga, Francisco and Diaz, Luis Antonio and MacDonald, John K and Im, Gene Y and Singal, Ashwani K and Jairath, Vipul and Khan, Mohammad Qasim and Arab, Juan Pablo},
  title = {Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-Analysis},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {3},
  pages = {606--620},
  doi = {10.1016/j.cgh.2025.05.016}
}
Kostenlos starten →